Baricitinib-induced paradoxical psoriasis.

Details

Serval ID
serval:BIB_88CDDBC93191
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Baricitinib-induced paradoxical psoriasis.
Journal
Journal of the European Academy of Dermatology and Venereology
Author(s)
Di Domizio J., Castagna J., Algros M.P., Prati C., Conrad C., Gilliet M., Wendling D., Aubin F.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
08/2020
Peer-reviewed
Oui
Volume
34
Number
8
Pages
e391-e393
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Abstract
Although recent drugs including biological agents and small molecules targeting key inflammatory mediators have revolutionized the management of different chronic inflammatory diseases, these treatments lead to the development of psoriasis-like skin lesions in 2-5% of treated patients called paradoxical psoriasis. <sup>1</sup> Here we report the first case of paradoxical psoriasis induced by baricitinib, a novel janus kinase (JAK) 1/2 inhibitor.
Keywords
JAK inhibitor, adverse event, baricitinib, psoriasis
Pubmed
Web of science
Create date
17/02/2020 17:55
Last modification date
23/10/2020 6:23
Usage data